ZYXI Zynex, Inc. Stock Quote

ZYXI [NASD]

Index	-	P/E	95.68	EPS (ttm)	0.15	Insider Own	0.50%	Shs Outstand	34.84M	Perf Week	-13.88%
Market Cap	622.71M	Forward P/E	20.77	EPS next Y	0.71	Insider Trans	-10.64%	Shs Float	19.56M	Perf Month	-6.08%
Income	5.40M	PEG	-	EPS next Q	0.11	Inst Own	33.10%	Short Float	18.89%	Perf Quarter	4.95%
Sales	89.00M	P/S	7.00	EPS this Y	-7.10%	Inst Trans	0.22%	Short Ratio	13.51	Perf Half Y	-20.74%
Book/sh	1.61	P/B	9.21	EPS next Y	105.17%	ROA	14.90%	Target Price	-	Perf Year	-17.84%
Cash/sh	0.80	P/C	18.64	EPS next 5Y	-	ROE	18.70%	52W Range	12.53 - 22.89	Perf YTD	10.18%
Dividend	-	P/FCF	-	EPS past 5Y	36.80%	ROI	15.90%	52W High	-35.21%	Beta	0.83
Dividend %	-	Quick Ratio	5.40	Sales past 5Y	47.10%	Gross Margin	77.60%	52W Low	18.36%	ATR	1.05
Employees	768	Current Ratio	6.50	Sales Q/Q	58.60%	Oper. Margin	11.40%	RSI (14)	43.18	Volatility	7.91% 6.23%
Optionable	Yes	Debt/Eq	0.01	EPS Q/Q	-123.60%	Profit Margin	10.20%	Rel Volume	0.92	Prev Close	14.92
Shortable	Yes	LT Debt/Eq	0.01	Earnings	Jul 29 AMC	Payout	0.00%	Avg Volume	273.40K	Price	14.83
Recom	2.20	SMA20	-6.10%	SMA50	-5.44%	SMA200	-3.42%	Volume	251,649	Change	-0.60%

Jul-16-21

Upgrade

B. Riley Securities

Neutral → Buy

$19.50

Jul-16-21

Upgrade

B. Riley Securities

Neutral → Buy

$19 → $19.50

Mar-09-21

Upgrade

Northland Capital

Market Perform → Outperform

$22.50

Feb-26-21

Downgrade

B. Riley Securities

Buy → Neutral

$19

Jan-29-21

Downgrade

Piper Sandler

Overweight → Neutral

$28 → $20

Jan-28-21

Downgrade

Northland Capital

Outperform → Market Perform

$22.50

Sep-14-20

Upgrade

H.C. Wainwright

Neutral → Buy

$25

Sep-09-20

Upgrade

Northland Capital

Market Perform → Outperform

$22.50

Jul-29-20

Upgrade

B. Riley FBR

Neutral → Buy

$28

Jul-20-20

Initiated

Piper Sandler

Overweight

$30

Jul-13-20

Downgrade

B. Riley FBR

Buy → Neutral

Jul-10-20

Reiterated

H.C. Wainwright

Neutral

$20 → $30

Jun-16-20

Downgrade

Northland Capital

Outperform → Market Perform

May-19-20

Downgrade

H.C. Wainwright

Buy → Neutral

$20

Apr-01-20

Initiated

Northland Capital

Outperform

$15

Sep-23-19

Initiated

H.C. Wainwright

Buy

$12

Jul-30-21 02:02AM	Zynex, inc (ZYXI) Q2 2021 Earnings Call Transcript Motley Fool -17.03%
Jul-29-21 06:25PM	Zynex Inc. (ZYXI) Surpasses Q2 Earnings Estimates Zacks
04:01PM	Zynex Announces 2021 Second Quarter Earnings PR Newswire
Jul-21-21 09:15AM	Zynex Schedules 2021 Second Quarter Earnings Call PR Newswire
Jul-16-21 07:12AM	Zynex Inc. (ZYXI) Stock Jumps 6.5%: Will It Continue to Soar? Zacks +10.66%
Jul-15-21 09:15AM	Zynex Announces 247% Order Growth and Increases Q2 Adjusted EBITDA Estimate PR Newswire +6.45%
Jul-14-21 08:39AM	What You Need To Know About Zynex, Inc.'s (NASDAQ:ZYXI) Investor Composition Simply Wall St.
Jul-13-21 09:15AM	Zynex Announces Uplisting to the Nasdaq Global Select Market® PR Newswire
Jul-08-21 09:15AM	Zynex to Present at the Ladenburg Thalmann Virtual Annual Healthcare Conference PR Newswire
Jun-30-21 10:08AM	Hedge Funds Are Selling Zynex, Inc. (ZYXI) Insider Monkey
Apr-30-21 05:30AM	Zynex, Inc (ZYXI) Q1 2021 Earnings Call Transcript Motley Fool -7.86%
Apr-29-21 06:15PM	Zynex Inc. (ZYXI) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:01PM	Zynex Announces 2021 First Quarter Earnings PR Newswire
02:15PM	Zynex, Inc. to Host Earnings Call ACCESSWIRE
Apr-20-21 09:15AM	Zynex Appoints Donald Gregg as Vice President of Sales and Operations of Monitoring Solutions Division PR Newswire
Apr-19-21 09:15AM	Zynex Schedules 2021 First Quarter Earnings Call PR Newswire
Apr-12-21 09:15AM	Zynex Announces 140% Year over Year Order Growth in Q1-2021 PR Newswire
Apr-09-21 09:15AM	Zynex Growth Leads to New Corporate Headquarters PR Newswire
Apr-08-21 10:53AM	Could The Market Be Wrong About Zynex, Inc. (NASDAQ:ZYXI) Given Its Attractive Financial Prospects? Simply Wall St.
Mar-30-21 09:15AM	Zynex Recognized as the Sixth Largest Biotechnology/Bioscience Company in Colorado PR Newswire
Mar-09-21 02:45AM	Zynex Plans To Buy Back $10M In Stock; Shares Jump Over 10% SmarterAnalyst +8.19%
Mar-08-21 09:15AM	Zynex Announces Share Buyback Program PR Newswire +10.10%
Feb-26-21 12:12PM	Why Zynex Stock Is Crashing Today Motley Fool -16.65%
09:30AM	Zynex, Inc (ZYXI) Q4 2020 Earnings Call Transcript Motley Fool
Feb-25-21 05:35PM	Recap: Zynex Q4 Earnings Benzinga -5.43%
04:01PM	Zynex Announces 2020 Fourth Quarter and Full Year Earnings PR Newswire
02:15PM	Zynex, Inc. to Host Earnings Call ACCESSWIRE
Feb-18-21 09:15AM	Zynex Schedules 2020 Fourth Quarter and Full-Year Earnings Call PR Newswire
Feb-04-21 06:49AM	What Type Of Shareholders Make Up Zynex, Inc.'s (NASDAQ:ZYXI) Share Registry? Simply Wall St.
Feb-03-21 12:47PM	Zynex Shows Improved Relative Price Performance; Still Shy Of Benchmark Investor's Business Daily
Jan-28-21 04:30PM	Zynex Appoints Anna Lucsok as Chief Operating Officer of Zynex Medical PR Newswire -6.54%
Jan-14-21 09:15AM	Zynex Announces Filing of Patent for Sepsis Monitor PR Newswire +11.38%
Jan-12-21 09:00AM	Zynex Announces 117% Year over Year Order Growth and Increases Adjusted EBITDA Estimate PR Newswire +6.05%
Jan-06-21 09:15AM	Zynex Announces a Second Utility Patent for Its Blood Volume Monitor PR Newswire +6.74%
07:49AM	3 Top Small-Cap Stocks to Buy in January Motley Fool
Dec-31-20 04:11AM	Why Zynex, Inc. (NASDAQ:ZYXI) Could Be Worth Watching Simply Wall St.
Dec-30-20 05:00AM	ZYXI: Zynex Medical Disruption Creates Opportunity Zacks Small Cap Research +5.56%
Dec-10-20 09:40PM	HIs ZYXI A Good Stock To Buy Now? Insider Monkey
Dec-01-20 05:34AM	I Built A List Of Growing Companies And Zynex (NASDAQ:ZYXI) Made The Cut Simply Wall St.
Nov-19-20 09:15AM	Zynex Ranked 13th in Revenue Growth Among Medical Device Companies PR Newswire
Nov-17-20 09:15AM	Zynex to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference PR Newswire
Oct-29-20 03:07PM	Zynex, Inc.'s (NASDAQ:ZYXI) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? Simply Wall St.
Oct-27-20 08:31PM	Zynex, Inc (ZYXI) Q3 2020 Earnings Call Transcript Motley Fool
05:20PM	Recap: Zynex Q3 Earnings Benzinga
04:01PM	Zynex Announces Third Quarter 2020 Earnings PR Newswire
Oct-23-20 09:15AM	Zynex Appoints Neil Friery as President and Chief Operating Officer of Monitoring Solutions Division PR Newswire
Oct-20-20 09:15AM	Zynex Schedules 2020 Third Quarter Earnings PR Newswire
Oct-13-20 02:38AM	Zynex Tanks 23% As Demand Hit By Covid-19; Street Stays Bullish SmarterAnalyst
Oct-12-20 11:35AM	Why Zynex Stock Is Tanking Today Motley Fool -22.96%
09:15AM	Zynex Announces 96% Year over Year Order Growth PR Newswire
Oct-06-20 09:15AM	Zynex Continued Growth Leads to a New Manufacturing and Warehouse Facility PR Newswire
Sep-23-20 02:42PM	Is There An Opportunity With Zynex, Inc.'s (NASDAQ:ZYXI) 46% Undervaluation? Simply Wall St.
Sep-14-20 10:16AM	Why Zynex's Stock Is Trading Higher Today Benzinga
Sep-10-20 09:00AM	Zynex Reaches 400 Salesperson Milestone Ahead of Schedule PR Newswire
Sep-04-20 12:01PM	Stocks With Rising Relative Strength: Zynex Investor's Business Daily
Sep-03-20 09:00AM	Zynex Reports 83% Order Growth for July and August PR Newswire
Aug-26-20 12:27PM	Zynex Shows Market Leadership With Jump To 82 RS Rating Investor's Business Daily
Aug-16-20 06:22AM	Have $3,000? Consider Buying These Small-Cap Stocks Motley Fool
Aug-05-20 08:20AM	Earnings Tell The Story For Zynex, Inc. (NASDAQ:ZYXI) Simply Wall St.
Jul-28-20 11:31PM	Zynex, Inc (ZYXI) Q2 2020 Earnings Call Transcript Motley Fool -5.13%
04:26PM	Recap: Zynex Q2 Earnings Benzinga
Jul-27-20 11:10AM	Zynex (ZYXI) to Report Q2 Earnings: What's in the Cards? Zacks
Jul-24-20 09:37PM	3 Great Healthcare Stocks to Watch Motley Fool
Jul-23-20 09:21AM	Zynex Schedules 2020 Second Quarter Earnings PR Newswire -6.26%
Jul-16-20 03:14PM	What Percentage Of Zynex, Inc. (NASDAQ:ZYXI) Shares Do Insiders Own? Simply Wall St. -5.23%
Jul-15-20 11:37AM	Why Zynex Stock Is Dropping Today Motley Fool -14.28%
Jul-14-20 11:43PM	Zynex, Inc. Prices Public Offering of Common Stock PR Newswire
04:10PM	Zynex Inc. Announces Proposed Public Offering of Common Stock PR Newswire
Jul-10-20 12:46PM	Why Zynex Stock Is Up Today Motley Fool +11.16%
Jul-09-20 09:15AM	Zynex Announces 37% Order Growth and Increases Q2 and Full-Year Revenue Estimates PR Newswire
Jun-15-20 02:46PM	Edited Transcript of ZYXI earnings conference call or presentation 28-Apr-20 8:15pm GMT Thomson Reuters StreetEvents +10.50%
Jun-14-20 08:08PM	Hedge Funds Cautiously Watching Zynex, Inc. (ZYXI) Insider Monkey
Jun-12-20 09:59AM	Dow Jones Today Rebounds 700 Points; Adobe Gets 10 Target Hikes As Zynex Rallies Investor's Business Daily
Jun-10-20 05:51PM	Zynex Set to Join S&P SmallCap 600 PR Newswire +6.30%
Jun-09-20 11:29AM	Agios Gets Orphan Drug Tag for Mitapivat to Treat Thalassemia Zacks -12.63%
May-21-20 10:59AM	Does Market Volatility Impact Zynex, Inc.'s (NASDAQ:ZYXI) Share Price? Simply Wall St.
May-18-20 09:11AM	Zynex Announces New Line of Products PR Newswire
May-14-20 03:45PM	Dow, S&P 500 Bounce Hard Off Lows; Take Profits In Zynex, Co-Diagnostics? Investor's Business Daily +6.24%
May-13-20 11:29AM	Zacks.com featured highlights include: ThermoGenesis, Minerva, Sprout Social, Black Diamond and Zynex Zacks -6.59%
May-12-20 04:20PM	Top Stock Picks for Week of May 11, 2020 Zacks -9.29%
May-05-20 10:55AM	Top Ranked Momentum Stocks to Buy for May 5th Zacks
May-04-20 08:11AM	New Strong Buy Stocks for May 4th Zacks +12.10%
Apr-29-20 02:01AM	Zynex, Inc (ZYXI) Q1 2020 Earnings Call Transcript Motley Fool
Apr-28-20 04:02PM	Zynex Announces 2020 First Quarter Earnings PR Newswire
12:53PM	What Is Zynex's (NASDAQ:ZYXI) P/E Ratio After Its Share Price Rocketed? Simply Wall St.
Apr-21-20 09:20AM	Zynex Schedules 2020 First Quarter Earnings PR Newswire
Apr-17-20 11:41AM	Will Zynex Continue to Surge Higher? Zacks
Apr-13-20 12:14PM	What Is Zynex's (NASDAQ:ZYXI) P/E Ratio After Its Share Price Rocketed? Simply Wall St.
Apr-07-20 09:24AM	Zynex Announces 126% Order Growth and Increases Q1 and Full-Year Revenue Estimates PR Newswire +6.61%
Apr-02-20 08:27AM	Zynex Sees Hammer Chart Pattern: Time to Buy? Zacks
Mar-30-20 09:15AM	Zynex Appoints Rachelle Van Burkleo Vice President of Sales PR Newswire
Mar-18-20 08:59PM	Edited Transcript of ZYXI earnings conference call or presentation 27-Feb-20 9:15pm GMT Thomson Reuters StreetEvents -10.96%
Mar-02-20 01:01PM	Zynex, Inc. Analysts Are Pretty Bullish On The Stock After Recent Results Simply Wall St. +7.76%
Feb-28-20 07:28AM	The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO Benzinga +9.23%
06:24AM	Top Ranked Momentum Stocks to Buy for February 28th Zacks
Feb-27-20 04:02PM	Zynex Announces 2019 Fourth Quarter and Full Year Earnings PR Newswire -5.62%
Feb-25-20 11:22AM	A Rising Share Price Has Us Looking Closely At Zynex, Inc.'s (NASDAQ:ZYXI) P/E Ratio Simply Wall St.
09:11AM	Zynex Receives FDA Clearance for its Blood Volume Monitor PR Newswire
09:10AM	Zynex, Inc. (ZYXI) Shares March Higher, Can It Continue? Zacks
Feb-21-20 12:38PM	Can Zynex, Inc.'s (NASDAQ:ZYXI) ROE Continue To Surpass The Industry Average? Simply Wall St. +8.01%

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. The company also supplies electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products; and distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers CM-1500, a blood volume monitor device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MOORHEAD DANIEL J	Chief Financial Officer	Jun 14	Sale	16.15	7,000	113,050	13,483	Jun 14 05:51 PM
MOORHEAD DANIEL J	Chief Financial Officer	Jun 11	Sale	16.29	15,000	244,350	20,483	Jun 14 05:51 PM
MOORHEAD DANIEL J	Chief Financial Officer	Jun 10	Sale	16.16	3,000	48,480	35,483	Jun 14 05:51 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience